AI assistant
Sending…
Pluri Inc. — Report Publication Announcement 2017
Oct 30, 2017
6990_rns_2017-10-30_92c37795-1c19-46af-98dd-0b54fb00bcf5.htm
Report Publication Announcement
Open in viewerOpens in your device viewer
_________ false
| �������� ��������� ���� | 2 380 |
| PLURISTEM THERAPEUTICS INC | |
| Corporation no: C12337-2001 | 8543 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 30/10/2017 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2017-02-095191 | Time of broadcast: 22:43 22:42:05 |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report onPublic offering - Oct 2017
Public_offering_-_Oct_2017_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: NASDAQ CM | Date of revision of form structure: 25/09/2017 |
| Address: Matam Park 5 , Haifa 31905 ISRAEL , Tel: 074-7107171 , Fax: 074-7107172 | |
| E-mail address: [email protected] Company site: www.pluristem.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: Yanay Yaacov Position of Signatory in the reporting corporation: Chief Executive Officer, Director Name of Employer Company: | |
| Address: Matam Park 5 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7108673 E-mail: [email protected] 1 | |
More from Pluri Inc.
Report Publication Announcement
2026
May 14
Interim / Quarterly Report
2026
May 14
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Apr 23
Report Publication Announcement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Capital/Financing Update
2026
Mar 27